ALB and melanoma: Svetomir M. et al. aim to include (NCT02020707) 36 patients diagnosed with stage IV melanoma that cannot be removed by surgery or with other types of gynecological cancers (cancer of the cervix, endometrium, ovary, fallopian tube, or peritoneal cavity) in a phase 1 clinical trial in order to determine the maximally tolerated dose of a regimen with nanoparticle albumin-bound–paclitaxel and bevacizumab [91].